Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Performance of ChatGPT-4 and Bard chatbots in responding to common patient questions on prostate cancer 177Lu-PSMA-617 therapy.
Belge Bilgin G, Bilgin C, Childs DS, Orme JJ, Burkett BJ, Packard AT, Johnson DR, Thorpe MP, Riaz IB, Halfdanarson TR, Johnson GB, Sartor O, Kendi AT. Belge Bilgin G, et al. Among authors: johnson gb. Front Oncol. 2024 Jul 12;14:1386718. doi: 10.3389/fonc.2024.1386718. eCollection 2024. Front Oncol. 2024. PMID: 39070149 Free PMC article.
Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer.
Zhang H, Orme JJ, Abraha F, Stish BJ, Lowe VJ, Lucien F, Tryggestad EJ, Bold MS, Pagliaro LC, Choo CR, Brinkmann DH, Iott MJ, Davis BJ, Quevedo JF, Harmsen WS, Costello BA, Johnson GB, Nathan MA, Olivier KR, Pisansky TM, Kwon ED, Dong H, Park SS. Zhang H, et al. Among authors: johnson gb. Clin Cancer Res. 2021 Dec 1;27(23):6376-6383. doi: 10.1158/1078-0432.CCR-21-2510. Epub 2021 Sep 30. Clin Cancer Res. 2021. PMID: 34593526 Free PMC article. Clinical Trial.
Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity.
Lucien F, Kim Y, Qian J, Orme JJ, Zhang H, Arafa A, Abraha F, Thapa I, Tryggestad EJ, Harmsen WS, Kosti J, Ali H, Lowe VJ, Johnson GB, Kwon ED, Dong H, Park SS. Lucien F, et al. Among authors: johnson gb. Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):725-737. doi: 10.1016/j.ijrobp.2022.05.037. Epub 2022 Jun 4. Int J Radiat Oncol Biol Phys. 2022. PMID: 35671867 Free PMC article.
Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor Burden.
Gococo-Benore DA, Kuhlman J, Parent EE, Sharma A, Accurso J, Yang M, Kendi AT, Johnson G, Sonbol MB, Hobday T, Halfdanarson TR, Starr J. Gococo-Benore DA, et al. J Nucl Med. 2023 Jun;64(6):880-884. doi: 10.2967/jnumed.122.264533. Epub 2023 Apr 20. J Nucl Med. 2023. PMID: 37080760 Free article.
Targeted Alpha-Particle Therapy: A Review of Current Trials.
Jang A, Kendi AT, Johnson GB, Halfdanarson TR, Sartor O. Jang A, et al. Among authors: johnson gb. Int J Mol Sci. 2023 Jul 19;24(14):11626. doi: 10.3390/ijms241411626. Int J Mol Sci. 2023. PMID: 37511386 Free PMC article. Review.
Low PSA radiographic disease progression on C11-choline PET.
Mahmoud AM, Ahmed ME, Kendi AT, Thorpe M, Johnson GB, Riaz IB, Orme JJ, Kwon ED, Andrews JR, Childs DS. Mahmoud AM, et al. Among authors: johnson gb. BJUI Compass. 2023 Oct 25;5(2):319-324. doi: 10.1002/bco2.308. eCollection 2024 Mar. BJUI Compass. 2023. PMID: 38371200 Free PMC article.
Theranostics and artificial intelligence: new frontiers in personalized medicine.
Belge Bilgin G, Bilgin C, Burkett BJ, Orme JJ, Childs DS, Thorpe MP, Halfdanarson TR, Johnson GB, Kendi AT, Sartor O. Belge Bilgin G, et al. Among authors: johnson gb. Theranostics. 2024 Mar 25;14(6):2367-2378. doi: 10.7150/thno.94788. eCollection 2024. Theranostics. 2024. PMID: 38646652 Free PMC article. Review.
156 results